8 research outputs found
Application of Infrared Thermography for Efficient Irrigation: A Review
Precision agriculture technologies have become more prominent and useful in prevailing commercial agriculture. Using precise amount of irrigation water will reduce the yield losses and minimises the possible water losses due to over irrigation. Irrigation opportunity time can be easily and effectively detected by infrared thermography. In infrared thermography heat patterns emitted from an object are used to create an infrared image. This image indicates the amount of energy emitted from the relevant object. This technique is non-invasive and can be used even from a distance. Promotion of this technology in agriculture is a good remedy for water scarcity and also to reduce the cost of production. The energy emitted by plants indicates the leaf temperature. There is a relationship between the leaf temperature and status of water within the plant. When the plants are in water stress, stoma gets closed to reduce the transpiration losses and as a result temperature rises up. In thermography this leaf temperature is measured and different levels of canopy temperatures are indicated in different colours and different shades of colours. Temperature values obtained from thermogram can be converted into crop water stress index (CWSI) and the status of water stress in crops can be understood with its use. According to the level of water stress amount of water to be applied can be determined. According to different colours in the thermal image water distribution can be planned. By using this technique, accurately crops can be irrigated on time before they acquire permanent wilting point and the water content in the root zone can be maintained in plant available water range. Further, this technique needs to be diffused more into the Sri Lankan agriculture sector as there are many farmers who are struggling with water scarcity. This paper is a comprehensive review of the possible application of the infrared thermography for irrigation scheduling, deciding the water distribution pattern in a crop field and a way to manage irrigation water efficiently.Keywords: Infrared thermography, Irrigation, CWSI, Temperatur
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons’ Data
We present a systematic analysis of the effects of synchronizing a large-scale, deeply characterized, multi-omic dataset to the current human reference genome, using updated software, pipelines, and annotations. For each of 5 molecular data platforms in The Cancer Genome Atlas (TCGA)—mRNA and miRNA expression, single nucleotide variants, DNA methylation and copy number alterations—comprehensive sample, gene, and probe-level studies were performed, towards quantifying the degree of similarity between the ‘legacy’ GRCh37 (hg19) TCGA data and its GRCh38 (hg38) version as ‘harmonized’ by the Genomic Data Commons. We offer gene lists to elucidate differences that remained after controlling for confounders, and strategies to mitigate their impact on biological interpretation. Our results demonstrate that the hg19 and hg38 TCGA datasets are very highly concordant, promote informed use of either legacy or harmonized omics data, and provide a rubric that encourages similar comparisons as new data emerge and reference data evolve. Gao et al. performed a systematic analysis of the effects of synchronizing the large-scale, widely used, multi-omic dataset of The Cancer Genome Atlas to the current human reference genome. For each of the five molecular data platforms assessed, they demonstrated a very high concordance between the ‘legacy’ GRCh37 (hg19) TCGA data and its GRCh38 (hg38) version as ‘harmonized’ by the Genomic Data Commons
Viewing comprehension: Students? learning preferences and strategies when studying from video
Speciation of inorganic chromium in river water by graphite furnace-atomic absorption spectrometry after chromabond NH 2
Vorapaxar in the secondary prevention of atherothrombotic events
Item does not contain fulltextBACKGROUND: Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through antagonism of PAR-1. METHODS: We randomly assigned 26,449 patients who had a history of myocardial infarction, ischemic stroke, or peripheral arterial disease to receive vorapaxar (2.5 mg daily) or matching placebo and followed them for a median of 30 months. The primary efficacy end point was the composite of death from cardiovascular causes, myocardial infarction, or stroke. After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients with a history of stroke owing to the risk of intracranial hemorrhage. RESULTS: At 3 years, the primary end point had occurred in 1028 patients (9.3%) in the vorapaxar group and in 1176 patients (10.5%) in the placebo group (hazard ratio for the vorapaxar group, 0.87; 95% confidence interval [CI], 0.80 to 0.94; P<0.001). Cardiovascular death, myocardial infarction, stroke, or recurrent ischemia leading to revascularization occurred in 1259 patients (11.2%) in the vorapaxar group and 1417 patients (12.4%) in the placebo group (hazard ratio, 0.88; 95% CI, 0.82 to 0.95; P=0.001). Moderate or severe bleeding occurred in 4.2% of patients who received vorapaxar and 2.5% of those who received placebo (hazard ratio, 1.66; 95% CI, 1.43 to 1.93; P<0.001). There was an increase in the rate of intracranial hemorrhage in the vorapaxar group (1.0%, vs. 0.5% in the placebo group; P<0.001). CONCLUSIONS: Inhibition of PAR-1 with vorapaxar reduced the risk of cardiovascular death or ischemic events in patients with stable atherosclerosis who were receiving standard therapy. However, it increased the risk of moderate or severe bleeding, including intracranial hemorrhage. (Funded by Merck; TRA 2P-TIMI 50 ClinicalTrials.gov number, NCT00526474.)